GUIDED THERAPEUTICS INC Earnings Per Share Diluted

Quick Answer

GUIDED THERAPEUTICS INC reported Earnings Per Share Diluted of $0.04 (loss) per share for the year ending 2025.

  • GUIDED THERAPEUTICS INC showed an increase of +20.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $1.31 (loss) per share | Q2 2015: $0.03 (loss) per share | Q3 2015: $1.75 (loss) per share | Q1 2016: $0.00 per share | Q2 2016: $52.95 (loss) per share | Q3 2016: $1.36 (loss) per share | Q1 2017: $0.22 (loss) per share | Q2 2017: $0.59 (loss) per share | Q3 2017: $0.35 (loss) per share | Q1 2018: $0.00 per share | Q2 2018: $1.24 per share | Q3 2018: $1.60 (loss) per share | Q1 2019: $0.07 (loss) per share | Q2 2019: $0.81 (loss) per share | Q3 2019: $0.04 (loss) per share | Q1 2020: $0.04 per share | Q2 2020: $0.57 (loss) per share | Q3 2020: $0.03 per share | Q1 2021: $0.04 (loss) per share | Q2 2021: $0.09 (loss) per share | Q3 2021: $0.00 per share | Q1 2022: $0.05 (loss) per share | Q2 2022: $0.04 (loss) per share | Q3 2022: $0.03 (loss) per share | Q1 2023: $0.02 (loss) per share | Q2 2023: $0.03 (loss) per share | Q3 2023: $0.01 (loss) per share | Q1 2024: $0.01 (loss) per share | Q2 2024: $0.01 (loss) per share | Q3 2024: $0.01 (loss) per share | Q1 2025: $0.01 (loss) per share | Q2 2025: $0.01 (loss) per share | Q3 2025: $0.01 (loss) per share.
  • Historical annual values: Fiscal year 2025: $0.04 (loss) per share | Fiscal year 2024: $0.05 (loss) per share | Fiscal year 2023: $0.07 (loss) per share | Fiscal year 2022: $0.15 (loss) per share | Fiscal year 2021: $0.18 (loss) per share | Fiscal year 2020: $0.04 (loss) per share | Fiscal year 2019: $0.58 (loss) per share | Fiscal year 2018: $0.01 per share | Fiscal year 2017: $0.00 per share.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: